Redistribution of body composition in patients with Graves' disease after iodine-131 treatment

被引:5
|
作者
Xie, L-J [1 ]
Zhou, H-J [2 ]
Li, J-F [1 ]
Zhang, F. [1 ]
Zeng, F-W [1 ]
Qin, L-P [1 ]
Chen, Y. [1 ]
Yuan, H-J [1 ]
Cheng, M-H [1 ]
机构
[1] Sun Yat Sen Univ, Dept Nucl Med, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Internal Med, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China
关键词
X-RAY ABSORPTIOMETRY; SERUM LEPTIN LEVELS; SKELETAL-MUSCLE; MASS INDEX; THYROID-HORMONE; RADIOIODINE TREATMENT; ENERGY-EXPENDITURE; HYPERTHYROIDISM; BONE; HYPOTHYROIDISM;
D O I
10.1038/ejcn.2014.232
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
OBJECTIVE: The objective of this study was to investigate body composition redistribution at 3 months after radioactive iodine therapy (RAI). METHODS: Eighty patients with Graves' disease (GD) for RAI and 18 volunteers were recruited. All patients underwent thyroid status test and dual-energy x-ray absorptiometry at baseline and 3 months after RAI. According to the second thyroid status test, patients were divided into the following groups: A, with aggravated hyperthyroidism; B-1, with improved hyperthyroidism; B-2, with euthyroidism; and B-3, with hypothyroidism. RESULTS: Total lean mass (LM) but fat mass (FM) and bone mineral content (BMC) of whole GD patients after RAI recovered to be not different with controls. Compared with baseline, in group A, FM in the left leg increased, and LM in left arm, right arm, trunk and total LM decreased (P<0.05). In B-2, FM in the head increased, and LM in the head, right arm, trunk and total LM increased (P<0.05). In B-3, FM in the right leg and total body fat percentage decreased, but FM in the head, android-to-gynoid fat ratio and body mass index increased (P<0.05); LM of all sites, weight and total mass increased (P<0.05); BMC in lumbar spine and left leg, and total BMC decreased (P<0.05). Body composition of unmentioned sites was retained after RAI in each group (P>0.05). CONCLUSIONS: Replenishment of LM gets priority rather than FM and BMC during the first 3 months after RAI, and the increase in LM starts from the upper body; head is the regional site in which FM recovery occurs first.
引用
收藏
页码:856 / 861
页数:6
相关论文
共 50 条
  • [21] THYROID STORM AND IODINE-131 TREATMENT
    CREUTZIG, H
    KALLFELZ, I
    HAINDL, J
    THIEDE, G
    HUNDESHAGEN, H
    LANCET, 1976, 2 (7977): : 145 - 145
  • [22] Contamination of the Isolation Room After Iodine-131 Ablation Treatment
    Levanen, K.
    Miettinen, N.
    Leskinen, H.
    Heikkinen, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S89 - S89
  • [23] Iodine-131 uptake and turnover rate vary over short intervals in Graves' disease
    Van Isselt, JW
    De Klerk, JMH
    Koppeschaar, HPF
    Van Rijk, PP
    NUCLEAR MEDICINE COMMUNICATIONS, 2000, 21 (07) : 609 - 616
  • [24] The preliminary clinical observation and analysis of childbearing-age women with a history of iodine-131 treatment for Graves' disease
    Guan, Liang
    Chen, Gang
    Zhang, Jiali
    Wang, Ling
    BIOSCIENCE TRENDS, 2016, 10 (04) : 307 - 314
  • [25] THYROID CARCINOGENESIS IN HAMSTERS AFTER TREATMENT WITH IODINE-131 AND METHYLTHIOURACIL
    CHRISTOV, K
    RAICHEV, R
    ZEITSCHRIFT FUR KREBSFORSCHUNG UND KLINISCHE ONKOLOGIE, 1972, 77 (03): : 171 - &
  • [26] Iodine-131: an option for the cholangiocarcinoma treatment?
    Ribeiro, A. C.
    Fernandes, A. I.
    Brito, A. F.
    Abrantes, A. M.
    Laranjo, M.
    Santos, K.
    Tralhao, J. G.
    Botelho, M. F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S640 - S640
  • [27] Does the dose of iodine-131 influence the incidence of Graves' ophthalmopathy?
    Khiyani, Neeraj
    Dadparvar, Simin
    Gish, Aaron
    Intenzo, Charles M.
    Malmud, Leon S.
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (05) : 455 - 460
  • [28] Study on the immunosuppression effects after iodine-131 treatment in patients with differentiated thyroid carcinoma
    Luo, QY
    Yu, YL
    Chen, LB
    Lu, HK
    Zhu, RS
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S426 - S427
  • [29] Evaluation of iodine-131 therapy for differentiated thyroid carcinoma patients with elevated thyroglobulin and negative iodine-131 whole body scan.
    Tian, R
    Qin, SW
    Kuang, RA
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 334P - 334P
  • [30] Influence of an additional application of iodine-127 on the pharmacokinetics of radioactive iodine-131 during a radioiodine therapy in patients with Graves' disease.
    Moka, D
    Reinholz, U
    Eschner, W
    Wellner, U
    Schicha, H
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 332P - 333P